Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
103.64B
Market cap103.64B
Price-Earnings ratio
21.60
Price-Earnings ratio21.60
Dividend yield
3.53%
Dividend yield3.53%
Average volume
10.20M
Average volume10.20M
High today
$81.86
High today$81.86
Low today
$79.66
Low today$79.66
Open price
$79.83
Open price$79.83
Volume
11.21M
Volume11.21M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

The current Medtronic(MDT) stock price is $80.98, with a market capitalization of 103.64B. The stock trades at a price-to-earnings (P/E) ratio of 21.60 and offers a dividend yield of 3.53%.

As of 2026-06-26, Medtronic(MDT) stock has fluctuated between $79.66 and $81.86. The current price stands at $80.98, placing the stock +1.7% above today's low and -1.1% off the high.

The Medtronic(MDT)'s current trading volume is 11.21M, compared to an average daily volume of 10.2M.

During the past year, Medtronic(MDT) stock moved between $73.31 at its lowest and $106.33 at its peak.

During the past year, Medtronic(MDT) stock moved between $73.31 at its lowest and $106.33 at its peak.

MDT News

Simply Wall St 8h
Renal Denervation Momentum Could Be A Game Changer For Medtronic’s Chronic Disease Strategy

In recent months, analysts have highlighted Medtronic’s progress in its Symplicity Spyral renal denervation system, which already has FDA approval and is on tra...

Renal Denervation Momentum Could Be A Game Changer For Medtronic’s Chronic Disease Strategy
Simply Wall St 2d
AngloGold Ashanti Stock Leads 3 Dividend Powerhouses Worth A Closer Look

With central banks sending mixed signals and growth indicators pointing in different directions across the US, Europe and Asia, reliable income has become a pri...

AngloGold Ashanti Stock Leads 3 Dividend Powerhouses Worth A Closer Look
Simply Wall St 4d
Accenture And 2 US Dividend Stocks With Stable Income And Growth

With inflation trends, rate expectations and energy headlines all pulling markets in different directions, many investors are looking for steadier cash flow fro...

Accenture And 2 US Dividend Stocks With Stable Income And Growth

Analyst ratings

64%

of 33 ratings
Buy
63.6%
Hold
36.4%
Sell
0%

More MDT News

Simply Wall St 6d
Medtronic Stock Could Be 12.2% Undervalued After Strong Revenue Growth

Advertisement Event driven interest in Medtronic stock Medtronic (MDT) is back in focus after reporting its strongest annual revenue growth in a decade, with...

Medtronic Stock Could Be 12.2% Undervalued After Strong Revenue Growth
TipRanks 7d
Medtronic Warns Broad Legal Risks Could Materially Impact Financial Performance

Medtronic (MDT) has disclosed a new risk, in the Litigation & Legal Liabilities category. Unlock powerful investing tools and data-driven insights with TipRank...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.